Thanks for your insight, very informative and valid points!

First 162 Last

Share
Profile

Follow
mattfarac

35 Posts.

1

09/08/20

18:26

Post #: 46409885
Share

Originally posted by Michaeljob: ↑

Anyone buying into this one should acknowledge that they have a bunch of shares on issue and are yet to really show their hand in terms of revenue growth. Most acknowledge this point. The thing however is that you have an all star cast, from what they’ve done before you get something of a feel for just how good these guys are. In a perfect world the market would now settle on a value around where we are now and await confirmation of delivery from the new guns.

The reality however is that this is the speculative end of the market and we’re going to be priced on what might happen in the future.

They might make a cash flow positive business from existing cash reserves, they might need a few more capital injections.

They might shoot the lights out and sign up some huge partners in the coming weeks, it may take years or never happen.

They might turn this to a multi billion dollar company, they might turn your investments to dust.

The thing is to understand that right now your invested in what might happen based on the sector and those managing this company. It’s yet to cement itself as a value investment.

For me personally it’s got all the right ingredients to succeed. If it does then 10 bags, maybe 100, who really knows. If it’s going to fail then chances are you know in the next 6 months. With the risk v’s reward on offer it’s currently a very easy hold. 60-80m MC without any major progress and I’d likely be a seller. For now though happy to hold and let a few of the maybe’s be answered.

PS, keep in mind and major run in a stock brings in a bunch of hot money, they’ll be gone in a week irrespective of the company’s merits so expect some volatility and plan your strategy appropriately. Don’t let the noise impact your choices, it comes and it goes.

Expand

Thanks for your insight, very informative and valid points!

ESH Price at posting: 1.4¢ Sentiment: Hold Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

AUG

Augustus sees imperial share rise on high-grade Cu and gold results at Ti-Tree

TX3

Canadian fieldwork yields multiple pegmatites for Trinex

I88

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

TLX

Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug

RNU

Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some

There are more pages in this discussion • 174 more messages in this thread...

First 162 Last

Add LU7 (ASX) to my watchlist

(20min delay)
Last 1.6¢		Change 0.000(0.00%)		Mkt cap ! $9.502M

Open	High	Low	Value	Volume
1.6¢	1.6¢	1.6¢	$81	5.049K

Buyers (Bids)

No.	Vol.	Price($)
5	1158716	1.6¢

Sellers (Offers)

Price($)	Vol.	No.
1.7¢	234996	4

View Market Depth

No.	Vol.	Price($)
5	1158716	0.016
8	1750248	0.015
6	1861320	0.014
8	1523922	0.013
3	682500	0.012

Price($)	Vol.	No.
0.017	234996	4
0.018	386519	3
0.019	2201904	2
0.020	1232273	4
0.021	550000	1

Last trade - 10.04am 11/07/2024 (20 minute delay)

LU7 (ASX) Chart

Thanks for your insight, very informative and valid points!

Augustus sees imperial share rise on high-grade Cu and gold results at Ti-Tree

Canadian fieldwork yields multiple pegmatites for Trinex

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug

Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Thanks for your insight, very informative and valid points!

Top Stories

Augustus sees imperial share rise on high-grade Cu and gold results at Ti-Tree

Canadian fieldwork yields multiple pegmatites for Trinex

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug

Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News